Results 191 to 200 of about 11,359,663 (315)

<i>Fusobacterium nucleatum</i> Lipopolysaccharides O‑Antigen Defines a Novel Siglec‑7 Binding Epitope. [PDF]

JACS Au
Di Carluccio C, Nieto-Fabregat F, Cerofolini L, Abreu C, Padilla-Cortés L, Gheorghita GR, Masi AA, Buono L, Gumah Adam Ali M, Lamprinaki D, Molinaro A, Juge N, Smaldone G, Vaněk O, Fragai M, Marchetti R, Silipo A.   +16 more
europepmc   +1 more source

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos, Marwa Al‐Dubai, Denise Walther, Dominic Borie, Jan D. Lünemann, Marc Pawlitzki, Sven G. Meuth, Solveig Henneicke, Stefan Vielhaber, Stefanie Schreiber   +9 more
wiley   +1 more source

Dual glycosylation of wall teichoic acid modulates the O-antigen pattern and virulence in serovar 4b <i>Listeria monocytogenes</i>. [PDF]

mLife
Yao H, Wang Y, Wang R, Dong Z, Wu Z, Wang L, Yin Y, Jiao X.   +7 more
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Molecular and functional analysis of the tumour antigen T21

, 2015
Immunotherapy is a valuable approach to target tumour cells by stimulating the body’s adaptive immune system. To achieve this objective, it is important to identify and study antigens that are distinctively expressed in cancer and can be used effectively
Alshehri, BM
core  

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro, Shiwen Koay, Gordon T. Ingle, Patricia McNamara, Laura Watson, Fion Bremner, Valeria Iodice   +6 more
wiley   +1 more source

Cross-comparison study of three ELISA methodologies to measure <i>Shigella Sonnei</i> O-antigen serum IgG. [PDF]

mSphere
Stickings P, Vipond C, Rigsby P, Micoli F, Rossi O, Mancini F, Conti V, Cohen D, Bialik A, Meron-Sudai S, Asato V, Clarkson KA, MacLennan CA, Kaminski RW.   +13 more
europepmc   +1 more source

Elucidation of the O-antigen structure of Escherichia coli O93 and characterization of its biosynthetic genes. [PDF]

Glycobiology, 2023
Furevi A, Ståhle J, Muheim C, Gkotzis S, Daley DO, Udekwu KI, Widmalm G.   +6 more
europepmc   +1 more source

Human Pegivirus Encephalitis With Brain Detection and Response to Sofosbuvir Ledipasvir

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Human pegivirus (HPgV‐1) has been associated with severe encephalomyelitis in immunocompromised patients. Its neurological spectrum remains poorly defined. We report a slowly progressive encephalitis in a person living with well‐controlled HIV, characterized by white matter abnormalities and inflammatory cerebrospinal fluid (CSF). HPgV RNA was
Antoine Moulignier, Françoise Heran, Francis Lallemand, Pierre Bourdillon   +3 more
wiley   +1 more source

<i>Shigella</i> Mutant with Truncated O-Antigen as an Enteric Multi-Pathogen Vaccine Platform. [PDF]

Vaccines (Basel)
Kim JO, Nothaft H, Moon Y, Jeong S, Vortherms AR, Song M, Szymanski CM, White J, Walker R.   +8 more
europepmc   +1 more source